×
Back to Agenda
Session 3: Turning fundamental research into innovative treatments
Session Chair(s)
Greg Jordinson, MSC
Policy Liaison, Johnson & Johnson, United Kingdom
Session 3: Turning fundamental research into innovative treatments
Speaker(s)
Greg Jordinson, MSC
Policy Liaison, Johnson & Johnson, United Kingdom
“The Value of the Innovation” – PhRMA Report
Mathieu Boudes, PHD
Patient Engagement Director, Montsouris Consilium, France
Patients Driving Innovation
Gracy G Crane, MS
Policy Lead , Roche, United Kingdom
The use of Real World Data in Regulatory Decision
Have an account?